Related Experiment Video
Updated: Dec 29, 2025
08:49
Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart
Published on: May 11, 2018
9.8K
Right Ventricular Assist Devices After Heart Transplantation
Sara Escalona-Rodriguez1, Nora Palomo-López1, Ana Escoresca-Ortega1
1Department of Intensive Care Medicine, Virgen del Rocio University Hospital, Seville, Spain.
Transplantation Proceedings
|February 10, 2020
Summary
Right ventricular failure (RVF) after heart transplant is common and increases mortality. Ventricular assist devices (VADs) may improve outcomes for high-risk patients needing post-transplant support.
Area of Science:
- Cardiology
- Cardiac Surgery
- Transplantation Medicine
Background:
- Right ventricular failure (RVF) is a significant complication post-cardiac transplant, independently increasing mortality.
- Ventricular assist devices (VADs) are crucial when medical management of RVF fails.
Purpose of the Study:
- To analyze outcomes of early RVF in heart transplant recipients requiring VAD support.
- To evaluate the efficacy of VADs in managing post-transplant RVF.
Main Methods:
- Retrospective analysis of adult heart transplant recipients requiring post-transplant mechanical circulatory support for RVF.
- Data collected included demographics, clinical details, complications, and survival rates.
Main Results:
- Ten patients were analyzed; 60% overall survival rate.
- Common indications included ischemic heart disease and dilated cardiomyopathy; 6 patients had preoperative pulmonary hypertension.
- High complication rates observed: 70% needed renal replacement therapy, 20% had stroke, 50% required tracheostomy.
Conclusions:
- RVF post-heart transplant is associated with significant complications and high mortality.
- Early VAD implantation in high-risk patients may be beneficial.
Related Concept Videos
01:29Cardiomyopathy V: Interprofessional Care
252
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
252
01:22Heart Failure VI: Adjunct Therapies
199
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
199
01:30Cardiomyopathy II: Dilated Cardiomyopathy
373
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
373